BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33621099)

  • 1. Evaluation of the Physicochemical Properties of the Iron Nanoparticle Drug Products: Brand and Generic Sodium Ferric Gluconate.
    Brandis JEP; Kihn KC; Taraban MB; Schnorr J; Confer AM; Batelu S; Sun D; Rodriguez JD; Jiang W; Goldberg DP; Langguth P; Stemmler TL; Yu YB; Kane MA; Polli JE; Michel SLJ
    Mol Pharm; 2021 Apr; 18(4):1544-1557. PubMed ID: 33621099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Snapshots of Iron Speciation: Tracking the Fate of Iron Nanoparticle Drugs via a Liquid Chromatography-Inductively Coupled Plasma-Mass Spectrometric Approach.
    Neu HM; Alexishin SA; Brandis JEP; Williams AMC; Li W; Sun D; Zheng N; Jiang W; Zimrin A; Fink JC; Polli JE; Kane MA; Michel SLJ
    Mol Pharm; 2019 Mar; 16(3):1272-1281. PubMed ID: 30676753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium ferric gluconate (SFG) in complex with sucrose for IV infusion: bioequivalence of a new generic product with the branded product in healthy volunteers.
    Baribeault D
    Curr Med Res Opin; 2011 Aug; 27(8):1653-7. PubMed ID: 21714710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Evaluation of U.S. Brand and Generic Intravenous Sodium Ferric Gluconate Complex in Sucrose Injection: Physicochemical Characterization.
    Sun D; Rouse R; Patel V; Wu Y; Zheng J; Karmakar A; Patri AK; Chitranshi P; Keire D; Ma J; Jiang W
    Nanomaterials (Basel); 2018 Jan; 8(1):. PubMed ID: 29303999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term stability of a new generic sodium ferric gluconate in complex with sucrose.
    Baribeault D
    Curr Med Res Opin; 2011 Dec; 27(12):2241-3. PubMed ID: 21992082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Evaluation of U.S. Brand and Generic Intravenous Sodium Ferric Gluconate Complex in Sucrose Injection: In Vitro Cellular Uptake.
    Wu M; Sun D; Tyner K; Jiang W; Rouse R
    Nanomaterials (Basel); 2017 Dec; 7(12):. PubMed ID: 29244729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Evaluation of U.S. Brand and Generic Intravenous Sodium Ferric Gluconate Complex in Sucrose Injection: Biodistribution after Intravenous Dosing in Rats.
    Beekman CR; Matta M; Thomas CD; Mohammad A; Stewart S; Xu L; Chockalingam A; Shea K; Sun D; Jiang W; Patel V; Rouse R
    Nanomaterials (Basel); 2017 Dec; 8(1):. PubMed ID: 29283393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermodynamic stability assessment of a colloidal iron drug product: sodium ferric gluconate.
    Yang Y; Shah RB; Faustino PJ; Raw A; Yu LX; Khan MA
    J Pharm Sci; 2010 Jan; 99(1):142-53. PubMed ID: 19492341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural characterization of iron oxide/hydroxide nanoparticles in nine different parenteral drugs for the treatment of iron deficiency anaemia by electron diffraction (ED) and X-ray powder diffraction (XRPD).
    Fütterer S; Andrusenko I; Kolb U; Hofmeister W; Langguth P
    J Pharm Biomed Anal; 2013 Dec; 86():151-60. PubMed ID: 23998966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physicochemical Characterization of Iron Carbohydrate Colloid Drug Products.
    Zou P; Tyner K; Raw A; Lee S
    AAPS J; 2017 Sep; 19(5):1359-1376. PubMed ID: 28762128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Core size determination and structural characterization of intravenous iron complexes by cryogenic transmission electron microscopy.
    Wu Y; Petrochenko P; Chen L; Wong SY; Absar M; Choi S; Zheng J
    Int J Pharm; 2016 May; 505(1-2):167-74. PubMed ID: 27001529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron management: innovative solutions to persistent challenges--focus on Ferrlecit.
    Vogel S; Schweitzer S; Seiler S
    ANNA J; 1999 Oct; 26(5):515-21. PubMed ID: 10776080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicochemical and structural characterization of iron-sucrose formulations: a comparative study.
    Barot BS; Parejiya PB; Mehta DM; Shelat PK; Shah GB
    Pharm Dev Technol; 2014 Aug; 19(5):513-20. PubMed ID: 23701359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium ferric gluconate complex in sucrose: safer intravenous iron therapy than iron dextrans.
    Faich G; Strobos J
    Am J Kidney Dis; 1999 Mar; 33(3):464-70. PubMed ID: 10070910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticle iron medicinal products - Requirements for approval of intended copies of non-biological complex drugs (NBCD) and the importance of clinical comparative studies.
    Borchard G; Flühmann B; Mühlebach S
    Regul Toxicol Pharmacol; 2012 Nov; 64(2):324-8. PubMed ID: 22951348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences between intravenous iron products: focus on treatment of iron deficiency in chronic heart failure patients.
    Martin-Malo A; Borchard G; Flühmann B; Mori C; Silverberg D; Jankowska EA
    ESC Heart Fail; 2019 Apr; 6(2):241-253. PubMed ID: 30694615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer), a new intravenous iron preparation and its clinical implications.
    Jahn MR; Andreasen HB; Fütterer S; Nawroth T; Schünemann V; Kolb U; Hofmeister W; Muñoz M; Bock K; Meldal M; Langguth P
    Eur J Pharm Biopharm; 2011 Aug; 78(3):480-91. PubMed ID: 21439379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron sucrose: assessing the similarity between the originator drug and its intended copies.
    Di Francesco T; Philipp E; Borchard G
    Ann N Y Acad Sci; 2017 Nov; 1407(1):63-74. PubMed ID: 29168243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability and stability of intravenous iron sucrose originator versus generic iron sucrose AZAD.
    Praschberger M; Cornelius C; Schitegg M; Goldenberg H; Scheiber-Mojdehkar B; Sturm B
    Pharm Dev Technol; 2015 Mar; 20(2):176-82. PubMed ID: 24219061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron-carbohydrate complexes treating iron anaemia: Understanding the nano-structure and interactions with proteins through orthogonal characterisation.
    Krupnik L; Avaro J; Liebi M; Anaraki NI; Kohlbrecher J; Sologubenko A; Handschin S; Rzepiela AJ; Appel C; Totu T; Blanchet CE; Alston AEB; Digigow R; Philipp E; Flühmann B; Silva BFB; Neels A; Wick P
    J Control Release; 2024 Apr; 368():566-579. PubMed ID: 38438093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.